Skip to content

A clinical research study for Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T)

A clinical research study to evaluating the safety and effectiveness of an
investigational drug (Mitapivat) in study participants with Transfusion-Dependent
Alpha- or Beta-Thalassemia (ENERGIZE-T)

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:
You may be eligible to participate in this trial if you are:
- ≥18 years of age
- have been diagnosed with thalassemia
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion Criteria:
You may not be eligible to participate in this trial if you:
- have received gene therapy or bone marrow or stem cell transplantation
- female who is breast feeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB21-0766